Shares of small-cap Brainstorm Cell Therapeutics Inc BCLI spiked more than 6 percent Friday morning after prominent neurosurgeon Dr. Sanjay Gupta tweeted there is now a "ray of hope" for millions of people that are suffering from Lou Gehrig's disease.
Market News and Data brought to you by Benzinga APIsfinally, a ray of hope for millions with the disease that killed lou gehrig: #als http://t.co/6hDmOfVX7a pic.twitter.com/yK1zaCurz1
— Dr. Sanjay Gupta (@drsanjaygupta) April 10, 2015
Brainstorm Cell Therapeutics is a biotechnology company developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson's disease (PD).
Gupta's tweet included a link to an article he had written on Everydayhealth.com. The doctor detailed a trial at the Mayo Clinic that that uses stem cells harvested from a patient's own body fat that are grown in a dish then injected into the spinal fluid.
The trial is still in the first phase, but there is hope that this treatment can slow or even halt the disease's progression, marking a huge step forward in managing the disease.
Shares of Brainstorm Cell Therapeutics traded recently at $4.55, up 5.3 percent.© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Health CareIntraday UpdateMoversGeneralBrainstorm Cell TherapeuticsLou Gehrig's DiseaseMayo ClinicSanjay Gupta
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in